Episode 51: Combating Coronavirus
Dr. Eric von Hofe, Chief Scientific Officer at NuGenerex Immuno-Oncology talks about the recent outbreak of Wuhan coronavirus around the world and how biotechs and pharma are jumping in to help find a solution.
15m Mar 05, 2020
15m
Episode 50: Pharma Pricing Climate in Washington
Mike Strazzella, head of federal government relations for Buchanan Ingersoll & Rooney, talks about pricing issues in the pharmaceutical industry, the challenges he encounters, and what he believes needs to change in the industry going forward.
20m Feb 20, 2020
20m
Episode 49: Navigate Emerging Markets with Data Science
Pharm Exec speaks with Nigel Breakwell and Ben Randal, co-founders of Dot I/O Health. Nigel and Ben talk about how they’re using data science in the health and life sciences industries to help clients navigate emerging markets.
24m Feb 06, 2020
24m
Episode 48: 2020 Industry Outlook
Pharm Exec editors discuss the themes chosen for the January issue focusing on industry trends for the coming year.
21m Jan 23, 2020
21m
Episode 47: Identifying Adherence Issues
Heather Monte, Director of Operations for DirectRx, talks about the specialty pharma’s new Patient Scorecard, which aims to identify and improve adherence by reporting patients’ prescription patterns to doctors.
10m Jan 09, 2020
10m
Episode 46: Persistence and Planning Pays Off
Julia Owens, co-founder and CEO of Millendo Therapeutics talks about how to keep a company on the path to success, even when there are bumps in the road. She discusses the value of focusing on strengths and how that is currently working for Millendo in the endocrine space.
14m Dec 19, 2019
14m
Episode 45: Getting Drug Approval Through FDA LPAD
William Lewis, chairman and CEO of Insmed talks about the approval of the company’s drug Arikayce through the FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs, some ideas that he spoke about on the recent NORD panel about innovative and ethical partnerships, and Insmed’s pipeline and progress.
27m Dec 05, 2019
27m
Episode 44: Annual Pipeline Report
Pharm Exec editors discuss the articles they focused on for the November Annual Pipeline Report.
19m Nov 21, 2019
19m
Episode 43: Pharma Reputation
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
23m Nov 07, 2019
23m
Episode 42: Establishing a New Drug Therapy
Pharm Exec editors interview Mark Glickman, Chief Commercial Officer of Esperion Therapeutics. Glickman discusses the overall cholesterol-lowering space and how it’s planning to add a new therapeutic option for patients, what it means to establish a new therapy in a statin-dominated market, market research approaches, and more.
15m Oct 17, 2019
15m
Episode 41: The Patient Journey
Jeannine Lynch, senior director at BioMarin Pharmaceuticals, oversees patient access services and talks with editors about the patient journey in regard to receiving therapies, how to engage with patients more effectively, and where she sees the pharma industry in terms of patient engagement and patient centricity.
27m Oct 03, 2019
27m
Episode 40: Global Pharma Outlook
Janssen’s company group chairman of Europe, Middle East, and Africa operations, Kris Sterkens speaks with Pharm Exec editors. Kris talks about his finance background, global pricing issues, and challenges and opportunities for EMEA biopharma breaking into the US market.
31m Sep 19, 2019
31m
Episode 39: CEO Builds Business With Compassion
Apellis’ CEO and co-founder, Dr. Cedric Francois talks with editors about his unusual pharma journey, which has included research, clinical work, and the launch of two startups. Today, he’s here to share what he’s learned along the way and how he’s using that experience to improve lives.
26m Sep 05, 2019
26m
Episode 38: Customer-Centric Innovation
Christine Sakdalan, Head of Franchise Strategy and Customer Solutions at Janssen Pharmaceutical talks with Pharm Exec editors about how patient-centricity fuels innovation, the difference between patient and customer centricity, and educational programs that need to be implemented for patients, providers, and payers.
14m Aug 22, 2019
14m
Episode 37: Differentiating Yourself in Crowded Therapeutic Areas
Pharm Exec editors sit down with Mark Velleca, CEO of G1 Therapeutics. In this episode, Mark talks about how he differentiates himself in the oncology field, why he considers G1 Therapeutics an "old school company," and about the North Carolina biotech landscape.
21m Aug 08, 2019
21m
Episode 36: A View from the Editors' Desks
Pharm Exec editors share insights into what they've been working on this summer for the June, July, and August issues; plus a sneak peek into what's coming in September!
31m Jul 25, 2019
31m
Episode 35: Communicating Your Narrative with Healthcare Marketing
Robert Finkel, the CEO of The FreshBlood Group talks with Pharm Exec editors about the positives and negatives of pharma’s marketing needs, the details and evolution around founding The FreshBlood Group, and how emerging pharma and biotech companies can budget in successful marketing.
27m Jul 11, 2019
27m
Episode 34: The Future of the Life Sciences Executive
Cameron Turtle, Chief Business Officer of Eidos Therapeutics, Robin Toft, Founder and CEO of The Toft Group Executive Search and Sabrina Johnson, President and CEO, Daré Bioscience join Pharm Exec editors to talk about the future of the life sciences executive.
23m Jun 21, 2019
23m
Episode 33: Translationally Enabled Pharma
Pharm Exec editors speak with Jigar Raythatha, CEO of Constellation Pharmaceuticals. He talks about his roles, the importance of having a Plan B in biotech, creating a translationally enabled company, and how he leads his team at Constellation.
27m Jun 11, 2019
27m
Episode 32: Change Your Behaviors, Change Your Health & Wellness
Pharm Exec's European Editor, Julian Upton, speaks with Johnson & Johnson's Jennifer Turgiss, VP Behavior Science & Advanced Analytics group. In their interview, Turgiss discusses behavioral strategies to the health and wellness solutions being developed at J&J.
18m May 23, 2019
18m
Episode 31: Ruling in Favor of Biotech
Editor-in-Chief Lisa Henderson speaks with Bill Newell, CEO of Sutro Biopharma about his background in corporate law and how it helps him in his role as a biotech executive, the importance of collaboration between big pharma and biotech, a story about keeping the San Francisco Giants in the Bay area, and other analogies around sports related to running a biotech.
20m May 10, 2019
20m
Episode 30: Challenges in Renal Disease Drug Development
Pharm Exec editors interview Anna Sundgren, the renal disease strategy leader, Global Medicines Development at AstraZeneca, about the current CVRM landscape, challenges to renal drug development, and new therapeutics for chronic kidney disease. This podcast was brought to you by QxMD.
21m Apr 25, 2019
21m
Episode 29: Disease Prevention & Interception
Pharm Exec's European Editor, Julian Upton, caught up with Ben Wiegand, head of J&J's World Without Disease Accelerator unit, at eyeforpharma Barcelona. They talk about Wiegand's panel "Uniting Patients, Providers, and Payers to Bring Preventative Care to Life," and J&J's disease prevention and interception activities. This podcast was brought to you by QxMD.
17m Apr 11, 2019
17m
Episode 28: Digital Medication
Michelle Maskaly and Christen Harm speak with Bill Carson, President & CEO of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Kabir Nath, President & CEO of Otsuka North America Pharmaceuticals about digital medicine, mental health therapies, and creating a smooth and collaborative relationship between R&D and commercial.
45m Mar 28, 2019
45m
Episode 27: Sensitive Topics in Pharma
Pharm Exec editors talk with Seth Lederman, co-founder, CEO and chairman of Tonix Pharmaceuticals about how to navigate creating drugs for conditions such as PTSD and AIDS, running a business, and academia.
23m Mar 15, 2019
23m
Episode 26: Patient Advocacy
Pharm Exec editors sit down with Bob Ward, chairman and CEO of Eloxx Pharmaceuticals, to talk about his personal, as well as Eloxx’s, commitment to working with patient advocacy groups, how to attract talent, and how to put together a great team.
16m Mar 01, 2019
16m
Episode 25: China’s Pharma Growth
Michelle Maskaly and Christen Harm talk with David Shao, CEO of Yisheng Biopharma, about what’s driving China’s exploding pharma and biotech industries, as well as the country’s push to become a global life science leader.
20m Feb 14, 2019
20m
Episode 24: 2019 Industry Trends
Michelle Maskaly and Christen Harm sit down with Editor-in-Chief Lisa Henderson and European Editor Julian Upton to discuss the industry trends featured in Pharm Exec's January 2019 issue.
26m Feb 05, 2019
26m
Episode 23: Mindfulness in Clinical Trial R&D
Pharm Exec editors Michelle Maskaly and Christen Harm speak with Raymond Sanchez, senior vice president of Global Clinical Development at Otsuka Pharmaceutical Development & Commercialization. Raymond talks about his switch from academia to clinical development, the sobering affect of seeing a drug he helped develop on the pharmacy shelf, and how he uses mindfulness to encourage and lead his team.
31m Jan 17, 2019
31m
Episode 22: Virtual Reality and Marketing in Healthcare
Nicola Kayel, Vice President of Marketing at Salix Pharmaceuticals, speaks with Pharm Exec editors about the challenges and strategies for marketing drugs that treat embarrassing conditions, like irritable bowel syndrome. She also discusses the company's recent plunge into virtual and augmented reality and how it plays a role in the future for healthcare professionals.
20m Dec 13, 2018
20m
Episode 21: Southeast Biotech
Jack Bailey, president of US pharmaceuticals for GlaxoSmithKline, talks with Christen Harm and Michelle Maskaly, about the biopharma landscape in the southeastern part of the United States, as part of Pharm Exec’s ongoing series that looks at growing biotech innovation hubs across the country. Bailey gives unmatched insights about the efforts North Carolina has put into growing, attracting, and...
32m Nov 29, 2018
32m
Episode 20: Analyzing the Pharma Pipeline
Pharm Exec Editorial Director Lisa Henderson and European Editor Julian Upton talk with Michelle Maskaly and Christen Harm about the magazine’s recent pharmaceutical pipeline report which was published in the November 2018 issue. Topics include cannabis, CAR-T therapy, opioids, biosimilars, and Alzheimer’s.
28m Nov 08, 2018
28m
Episode 19: How a CEO pivots Their Company and Career
Christen and Michelle talk with Mei Mei Hu, CEO of United Neuroscience, about how being open to pivoting from your original plan can create a number of opportunities for an executive and their company, as well as how her executive team successfully manages a remote workforce spread across three continents. In a hilarious conversation about balancing professional and personal life, Hu also talks...
19m Oct 25, 2018
19m
Episode 18: Data’s Influence on the Pharma C-suite
Michelle and Christen sit down with one of this year's Emerging Pharma Leaders, Christopher Boone, the head of real-world data and analytics center of excellence at Pfizer. We discuss what peaked Boone's interest in public health and data; the progression of how pharma and data have merged; what challenges pharma faces with data and what lies ahead; and where he got his infamous twitter handle.
24m Oct 11, 2018
24m
Episode 17: Commercializing Research
On Target Laboratories, CEO and Co-Founder, Martin R. Low and Philip S. Low, whose work the company is based off of and is also a co-founder of the company, join Christen Harm and Michelle Maskaly to talk about the ups and downs of commercializing research that has been previously shelved. They share how they approached another company to license the technology, why being persistent is a good t...
28m Sep 27, 2018
28m
Episode 16: Specialty Pharma
Pharm Exec’s Editor-in-Chief Lisa Henderson and European Editor Julian Upton join Christen Harm and Michelle Maskaly to talk about the topic of specialty pharma, which was featured in the magazine’s September issue. They discuss the marketing, logistics, pricing, and other challenges executives in the specialty pharma industry face, as well as dive into the forces that are driving this segment ...
26m Sep 13, 2018
26m
Episode 15: Impact of Robotics in Pharma
Learn how pharma companies are using robotics and artificial intelligence when it comes to patient care, what the funding landscape is for businesses in this sector, and as a member of the c-suite find out what you need to do now to be at the forefront of this emerging technology.
26m Aug 23, 2018
26m
Episode 14: Emerging Biotech in NYC
Nancy Thornberry, CEO of Kallyope, talks with Michelle Maskaly and Christen Harm about New York City as an emerging hotspot for biotech incubators, and the challenges and opportunities related to space, location, recruitment, and funding.
17m Aug 02, 2018
17m
Episode 13: How to Run a Successful Clinical-Stage Pharma Startup
Jeffrey Nau is CEO of Oyster Point Pharma, a clinical stage pharmaceutical company focused on developing commercial therapies dealing with parasympathetic pathways. In a climate where oncology and rare diseases get most of the attention, Nau talks about what it’s like working on diseases that don’t get the same press, like dry eye, which is the focus of their current Phase 2 clinical trial. How...
32m Jul 19, 2018
32m
Episode 12: Midwest Biotechs and Regenerative Medicine
Gil Van Bokkelen, CEO and co-founder of Athersys, talks about a pivotal moment during medical school that led him and his co-founders to eventually launch Athersys, the decision to start the company in Ohio instead of his native Northern California, and the secret to staying resilient in the c-suite even when facing extraordinary challenges.
32m Jul 06, 2018
32m
Episode 11: From Field to Boardroom with Former NFL Star Solomon Wilcots
Former NFL star and current sports broadcaster, Solomon Wilcots talks about the intersection of sports and biopharma. He discusses traumatic brain injuries and whether or not the NFL is doing enough about it, projects he has been working on that match professional athletes who are passionate about a certain disease with biopharma companies, and how lessons from the football field can be applied...
29m Jun 25, 2018
29m
Episode 10: Mentoring and Sponsoring
Michelle Maskaly and Christen Harm host one of Pharm Exec's Emerging Pharma Leaders, Sabina Ewing, vice president of business technology for Pfizer, and discuss the difference and importance of mentoring and sponsoring in business and pharma. Leadership Tip from Sabina Ewing.
27m Jun 07, 2018
27m
Episode 9: 2018 PE Brands of the Year
Michelle Maskaly and Christen Harm host the entire Pharmaceutical Executive editorial team on this episode, as we each talk about our Brands of the Year selections and why we chose them. Leadership Tip from Molly Herbert.
33m May 24, 2018
33m
Episode 8: CFO Insights From the Field
Tim Sullivan, CFO of Apellis Pharmaceuticals, gives an inside look at what it takes to be the CFO of a development-stage biotech company, and what business skills someone needs to succeed in that type of position. Leadership tip from Tim Sullivan.
23m May 15, 2018
23m
Episode 7: Big-Event Insights
Pharm Exec editors discuss key takeaways from a variety of industry conferences that took place across the globe. Leadership Tip by Julia Cheek, CEO of EverlyWell.
22m Apr 26, 2018
22m
Episode 6: The Pharma vs. Biotech Experience
Christen Harm and Michelle Maskaly interview Lara Sullivan, founder and president of SpringWorks Therapeutics, about the differences in working for legacy pharma vs. small biotech start-ups. Leadership Tip from Lara Sullivan.
25m Apr 12, 2018
25m
Episode 5: Med Affairs Training
Dr. William Soliman shares the story of how the Accreditation Council for Medical Affairs went from an idea in his head to a training program today that has enrolled more than 3,000 people and is setting new standards for medical affairs professionals. Leadership Tip from William Soliman.
17m Mar 26, 2018
17m
Episode 4: Outcomes-Based Contracting
In this episode, Michelle Maskaly and Christen Harm talk with Editor-in-Chief Lisa Henderson and European Editor Julian Upton about outcomes-based contracting from the March issue. Leadership tip from Molly Herbert.
26m Mar 16, 2018
26m
Episode 3: Pharma's Reputation
Michelle Maskaly and Christen Harm talk to Devyn Smith, chief strategy officer and head of operations for Sigilon Therapeutics on the topic of pharma's reputation, both in the US and Europe. Leadership Tip from Devyn Smith.
18m Feb 23, 2018
18m
Episode 2: JPMorgan Healthcare Conference 2018
In this episode, Michelle Maskaly and Christen Harm speak with Marc O'Connor, chief operating officer at Curant Health, and Pharm Exec's Editor-in-Chief, Lisa Henderson with insights on the JPMorgan Healthcare Conference that took place at the beginning of January. Leadership Tip from Marc O'Connor, chief operating officer at Curant Health.
34m Feb 12, 2018
34m